Article
Increased tau expression in the <i>APOE4</i> blood-brain barrier model is associated with reduced anti-tau therapeutic antibody delivery <i>in vitro</i>
2023-10-25
Abstract excerpt
Tau protein is a critical driver of neurodegeneration and an important drug target in Alzheimer’s disease (AD). Tau-specific immunotherapy has emerged as a promising treatment strategy for AD, however the therapeutic efficacy of anti-tau antibodies may be limited by their insufficient delivery across the blood-brain barrier (BBB). The apolipoprotein E4 allele ( APOE4 ) is the strongest genetic risk factor for spo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- efbe6227-c762-5c5b-a5f3-5ae463b64b1c
- DOI
- 10.1101/2023.10.24.563706
